NO992296D0 - FremgangsmÕte for disubstituerte pyridiner - Google Patents

FremgangsmÕte for disubstituerte pyridiner

Info

Publication number
NO992296D0
NO992296D0 NO992296A NO992296A NO992296D0 NO 992296 D0 NO992296 D0 NO 992296D0 NO 992296 A NO992296 A NO 992296A NO 992296 A NO992296 A NO 992296A NO 992296 D0 NO992296 D0 NO 992296D0
Authority
NO
Norway
Prior art keywords
disubstituted pyridines
pyridines
disubstituted
Prior art date
Application number
NO992296A
Other languages
English (en)
Norwegian (no)
Other versions
NO992296L (no
Inventor
Keith Michael Devries
Robert Lee Dow
Stephen Wayne Wright
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO992296D0 publication Critical patent/NO992296D0/no
Publication of NO992296L publication Critical patent/NO992296L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
NO992296A 1996-11-14 1999-05-12 FremgangsmÕte for disubstituerte pyridiner NO992296L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3088096P 1996-11-14 1996-11-14
PCT/IB1997/001367 WO1998021184A1 (en) 1996-11-14 1997-11-03 Process for substituted pyridines

Publications (2)

Publication Number Publication Date
NO992296D0 true NO992296D0 (no) 1999-05-12
NO992296L NO992296L (no) 1999-05-12

Family

ID=21856496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992296A NO992296L (no) 1996-11-14 1999-05-12 FremgangsmÕte for disubstituerte pyridiner

Country Status (32)

Country Link
US (1) US6291489B1 (US06291489-20010918-C00091.png)
EP (1) EP0938476B1 (US06291489-20010918-C00091.png)
JP (1) JP3510635B2 (US06291489-20010918-C00091.png)
KR (1) KR20000053314A (US06291489-20010918-C00091.png)
CN (1) CN1237160A (US06291489-20010918-C00091.png)
AP (1) AP805A (US06291489-20010918-C00091.png)
AR (1) AR010584A1 (US06291489-20010918-C00091.png)
AT (1) ATE319687T1 (US06291489-20010918-C00091.png)
AU (1) AU4634697A (US06291489-20010918-C00091.png)
BG (1) BG103393A (US06291489-20010918-C00091.png)
BR (1) BR9712951A (US06291489-20010918-C00091.png)
CA (1) CA2270386C (US06291489-20010918-C00091.png)
CO (1) CO4930261A1 (US06291489-20010918-C00091.png)
DE (1) DE69735433D1 (US06291489-20010918-C00091.png)
EA (1) EA199900375A1 (US06291489-20010918-C00091.png)
GT (1) GT199700118A (US06291489-20010918-C00091.png)
HR (1) HRP970612A2 (US06291489-20010918-C00091.png)
ID (1) ID18898A (US06291489-20010918-C00091.png)
IL (1) IL129688A0 (US06291489-20010918-C00091.png)
IS (1) IS5029A (US06291489-20010918-C00091.png)
MA (1) MA24401A1 (US06291489-20010918-C00091.png)
MY (1) MY132507A (US06291489-20010918-C00091.png)
NO (1) NO992296L (US06291489-20010918-C00091.png)
OA (1) OA11044A (US06291489-20010918-C00091.png)
PA (1) PA8441401A1 (US06291489-20010918-C00091.png)
PE (1) PE10299A1 (US06291489-20010918-C00091.png)
TN (1) TNSN97172A1 (US06291489-20010918-C00091.png)
TR (1) TR199901063T2 (US06291489-20010918-C00091.png)
UY (1) UY24774A1 (US06291489-20010918-C00091.png)
WO (1) WO1998021184A1 (US06291489-20010918-C00091.png)
YU (1) YU22099A (US06291489-20010918-C00091.png)
ZA (1) ZA9710186B (US06291489-20010918-C00091.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511460A (ja) * 1998-04-08 2002-04-16 ノバルティス アクチエンゲゼルシャフト 新規除草剤
US6090942A (en) * 1998-10-15 2000-07-18 Pfizer Inc. Process and intermediates for a β3 -adrenergic receptor agonist
US6515134B1 (en) * 1999-02-16 2003-02-04 Kaneka Corporation Substituted acetylpridine derivatives and process for the preparation of intermediates for optically active beta-3 agonist by the use of the same
US6455734B1 (en) 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
ATE280167T1 (de) * 1999-07-23 2004-11-15 Pfizer Prod Inc Zwischenprodukte und ein verfahren zur herstellung von beta3-adrenergischer rezeptor- agoniste
JPWO2003033468A1 (ja) * 2001-10-17 2005-02-03 株式会社カネカ (S)−α−ハロメチルピリジンメタノール誘導体の製造方法
AU2003248352A1 (en) 2002-02-27 2003-09-09 Pfizer Products Inc. PROCESSES AND INTERMEDIATES USEFUL IN PREPARING Beta3-ADRENERGIC RECEPTOR AGONISTS
AU2003209527A1 (en) * 2002-02-27 2003-09-09 Pfizer Products Inc. Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
US6864268B2 (en) 2002-02-27 2005-03-08 Pfizer Inc. β3 adrenergic receptor agonists
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
KR100751163B1 (ko) 2003-05-09 2007-08-22 에프. 호프만-라 로슈 아게 알파-1 아드레날린 작용물질로서의 메틸 인돌 및 메틸피롤로피리딘
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
JP5791500B2 (ja) 2008-05-23 2015-10-07 パンミラ ファーマシューティカルズ,エルエルシー. 5−リポキシゲナーゼ活性化タンパク質阻害剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358455A (en) 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
US5019578A (en) 1987-11-27 1991-05-28 Merck & Co., Inc. β-adrenergic agonists
NZ265692A (en) 1993-06-14 1997-02-24 Pfizer Indole- and benzofuran- containing hydroxyamines and analogs; pharmaceutical compositions
IL113410A (en) 1994-04-26 1999-11-30 Merck & Co Inc Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
JPH11504648A (ja) 1995-05-10 1999-04-27 ファイザー・インコーポレーテッド β−アドレナリン作動性アゴニスト
EP0824519A1 (en) 1995-05-10 1998-02-25 Pfizer Inc. Beta-adrenergic agonists

Also Published As

Publication number Publication date
UY24774A1 (es) 1998-05-05
MY132507A (en) 2007-10-31
ID18898A (id) 1998-05-20
ATE319687T1 (de) 2006-03-15
JP2000504347A (ja) 2000-04-11
ZA9710186B (en) 1999-05-12
DE69735433D1 (de) 2006-05-04
AR010584A1 (es) 2000-06-28
IL129688A0 (en) 2000-02-29
MA24401A1 (fr) 1998-07-01
PE10299A1 (es) 1999-02-10
WO1998021184A1 (en) 1998-05-22
AU4634697A (en) 1998-06-03
KR20000053314A (ko) 2000-08-25
OA11044A (en) 2002-02-20
TNSN97172A1 (fr) 2005-03-15
AP805A (en) 2000-01-28
TR199901063T2 (xx) 1999-08-23
IS5029A (is) 1999-04-16
CA2270386A1 (en) 1998-05-22
NO992296L (no) 1999-05-12
PA8441401A1 (es) 2000-05-24
CO4930261A1 (es) 2000-06-27
EP0938476B1 (en) 2006-03-08
YU22099A (sh) 2001-09-28
HRP970612A2 (en) 1998-08-31
BG103393A (en) 2000-07-31
EP0938476A1 (en) 1999-09-01
CA2270386C (en) 2004-08-03
AP9701147A0 (en) 1998-01-31
BR9712951A (pt) 1999-12-07
CN1237160A (zh) 1999-12-01
US6291489B1 (en) 2001-09-18
EA199900375A1 (ru) 1999-12-29
JP3510635B2 (ja) 2004-03-29
GT199700118A (es) 1999-05-05

Similar Documents

Publication Publication Date Title
NO990531L (no) Partikkel-siktanordning
DE69627112D1 (de) Bettvorrichtung
DE69621432T2 (de) Bettvorrichtung
DE69520558T2 (de) Halogenierungsverfahren
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
NO992296D0 (no) FremgangsmÕte for disubstituerte pyridiner
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
DE69703305D1 (de) System zum herstellen von polsterelementen
DE69708277T2 (de) Azeotroper destillationsprozess
IT1291359B1 (it) Procedimento per fabbricare pannelli truciolari
ATE249436T1 (de) Herstellungsverfahren
DE69729051D1 (de) Bearbeitungsbetriebsmethode
DE69507032D1 (de) Chlorhydrin-verfahren
NO20003079D0 (no) Polymerisasjon-oppstartningsprosess
MA24472A1 (fr) Procede
ID24830A (id) Proses untuk pengolahan laktam
MA24470A1 (fr) Procede
DE69708229T2 (de) Muster-Herstellungsverfahren
NO20003080D0 (no) Polymerisasjon-oppstartningsprosess
DE69811000T2 (de) System zum Herstellen von Bändern
DE29607349U1 (de) Vorrichtung zum Sichern von Türen
BR9709960A (pt) N-(4-piridil)-tioamidas substituídas
FI980701A (fi) Menetelmä prosessin kestoajan tarkistamiseksi
LV10943A (lv) N-benziloksikarbonilarginina 4-metilkumaril-7-amida iegusanas metode
ID23162A (id) Proses untuk mendekomposisi sikloalkilhidroperoksida

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application